Titlebook: Renal Cancer; Contemporary Managem John A. Libertino,Jason R. Gee Book 2020Latest edition Springer Nature Switzerland AG 2020 Renal Cell Ca

Pantry

Andrew G. McIntosh,Eric C. Umbreit,Christopher G. Woodtasets from electronic health records or telemonitoring programmes. The book’s promise is .“no math, no code”.and will explain the topics in a style that is optimized for a healthcare audience..978-3-319-99713-1

催眠

親密

Rationale for Partial Nephrectomy, Current Practice Patterns,and retrospective studies have demonstrated that PN carries a lower risk of long-term renal dysfunction, and have demonstrated oncologic outcomes equivalent to RN. As such, elective PN is considered the preferred treatment for patients requiring intervention for cT1a and select cT1b renal masses. Th

Foreshadow

起來(lái)了

Role of Lymphadenectomy in Renal Cell Cancer,taging role of LND and because some of them may benefit from a therapeutic effect. Conversely, lately some recent studies presented data contesting a therapeutic benefit for LND, suggesting only a staging role of LND in the contemporary surgical management of RCC. In this chapter, the available evid

雄辯

Role of Surgery in Locally Recurrent and Metastatic Renal Cancer,y has been demonstrated to have a role in the management of these patients but again must be undertaken with a clear understanding of the risks of surgery. Several retrospective series have demonstrated excellent survival in well-selected patients undergoing surgical management of metastatic disease

BLANC

Management of Non-Clear Cell Renal Cell Carcinoma,ctor (VEGF) agents, mammalian target of rapamycin (mTOR) inhibitors, and immune checkpoint inhibitors (ICIs) have made a large impact in the management of advanced clear cell renal cell carcinoma, their efficacy in non-clear cell histologies is still being defined. As we learn more about these tumor

痛苦一生

Mercurial

Firefly